h7n9 anhui 2013/aa ca
Vaccineexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2013 (NCT01928472)
Timeline
2010s
- Jan 1, 2013
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Influenza A virusImmunity, active
Influenza A virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- h7n9 anhui 2013/aa ca
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02274545 | Phase 1 | Oct 1, 2014 | National Institute of Allergy and Infectious Diseases (NIAID), University of Rochester |
| NCT01928472 | Phase 1 | Aug 1, 2013 | Novartis |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 1 | 1 | 1 | 2014 |
| Novartis | For profit | 1 | 1 | 1 | 2013 |
| University of Rochester | Academic/Hospital | 1 | 0 | 1 | 2014 |
3 organizations
Page 1 / 1